US Stock MarketDetailed Quotes
FUSN Fusion Pharmaceuticals
- 21.420
- -0.010-0.05%
Close May 1 16:00 ET
1.82BMarket Cap-14772P/E (TTM)
21.580High21.390Low555.55KVolume21.410Open21.430Pre Close11.94MTurnover0.88%Turnover RatioLossP/E (Static)84.87MShares21.58052wk High8.17P/B1.36BFloat Cap2.31052wk Low--Dividend TTM63.27MShs Float21.580Historical High--Div YieldTTM0.89%Amplitude1.980Historical Low21.495Avg Price1Lot Size
About Fusion Pharmaceuticals Company
Fusion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It develops GMP manufacturing of radiopharmaceuticals for the diagnosis and treatment of disease. The company was founded by John Vaillant in 2014 and is headquartered in Hamilton, Canada.
Company Profile
SymbolFUSN
Company NameFusion Pharmaceuticals
Listing DateJun 26, 2020
Issue Price17.00
Founded2014
CEODr. John Valliant, PhD
MarketNASDAQ
Employees113
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address270 Longwood Road South
CityHamilton
ProvinceOntario
CountryCanada
Zip CodeL8P 0A6
Phone1-289-799-0891
Websitehttp://www.fusionpharma.com
Company Executives
- Name
- Position
- Salary
- Dr. John Valliant, PhD
- Chief Executive Officer and Director
- 2.75M
- Eric Burak, PhD
- Chief Technology Officer
- 1.42M
- Mohit Rawat
- President and Chief Business Officer
- --
- Dr. Christopher P. Leamon, PhD
- Chief Scientific Officer
- --
- John Crowley
- Chief Financial Officer
- 1.44M
- Dmitri Bobilev
- Chief Medical Officer
- --
- Barbara G. Duncan
- Chairman of the Board
- 118.95K
- Teresa Marie Bitetti
- Director
- --
- David D. Meek
- Director
- --
- Dr. Jeremy Bender
- Director
- --
- Dr. Donald A. Bergstrom, M.D.,PhD
- Independent Director
- 87.95K
- Dr. Pablo J. Cagnoni, M.D.
- Independent Director
- 92.95K
- Steven Gannon
- Independent Director
- 97.95K
- Dr. Philina Lee, PhD
- Independent Director
- 89.95K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg